Application

NGMBIO

NGM Biopharmaceuticals, Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97124968
Filing Date: 11/15/2021

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 97124968
MARK INFORMATION
*MARK \\TICRS\EXPORT18\IMAGEOUT 18\971\249\97124968\xml1 \ APP0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT NGMBIO
COLOR MARK NO
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of the combined words ngmBIO with "ngm" in lowercase stylized letters and "BIO" in uppercase stylized letters.
PIXEL COUNT ACCEPTABLE YES
PIXEL COUNT 343 x 265
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK NGM Biopharmaceuticals, Inc.
*MAILING ADDRESS 333 Oyster Point Boulevard
*CITY South San Francisco
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
94080
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION House mark for a line of pharmaceutical products; pharmaceutical preparations
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 042 
*IDENTIFICATION Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 044 
*IDENTIFICATION Providing medical information relating to cancer, retinal diseases and liver and metabolic diseases
FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
ACTIVE PRIOR REGISTRATION(S) The applicant claims ownership of active prior U.S. Registration Number(s) 4954969, 4954958, 4954965, and others.
ATTORNEY INFORMATION
NAME Ilene B. Tannen
ATTORNEY DOCKET NUMBER 013370-0507
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Jones Day
STREET 250 Vesey Street
CITY New York
STATE New York
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 10281
PHONE 212-326-3411
FAX 212-755-7306
EMAIL ADDRESS nytef@jonesday.com
CORRESPONDENCE INFORMATION
NAME Ilene B. Tannen
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE nytef@jonesday.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) ibtannen@jonesday.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 3
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 1050
*TOTAL FEES PAID 1050
SIGNATURE INFORMATION
SIGNATURE NOT PROVIDED
SIGNATORY'S NAME NOT PROVIDED
SIGNATORY'S POSITION NOT PROVIDED
DATE SIGNED NOT PROVIDED



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 97124968
Filing Date: 11/15/2021

To the Commissioner for Trademarks:

MARK: NGMBIO (stylized and/or with design, see mark)
The literal element of the mark consists of NGMBIO. The applicant is not claiming color as a feature of the mark. The mark consists of the combined words ngmBIO with "ngm" in lowercase stylized letters and "BIO" in uppercase stylized letters.
The applicant, NGM Biopharmaceuticals, Inc., a corporation of Delaware, having an address of
      333 Oyster Point Boulevard
      South San Francisco, California 94080
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  House mark for a line of pharmaceutical products; pharmaceutical preparations
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 044:  Providing medical information relating to cancer, retinal diseases and liver and metabolic diseases
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



Claim of Active Prior Registration(s)
The applicant claims ownership of active prior U.S. Registration Number(s) 4954969, 4954958, 4954965, and others.


The owner's/holder's proposed attorney information: Ilene B. Tannen. Ilene B. Tannen of Jones Day, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is located at
      250 Vesey Street
      New York, New York 10281
      United States
      212-326-3411(phone)
      212-755-7306(fax)
      nytef@jonesday.com
The docket/reference number is 013370-0507.
Ilene B. Tannen submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:
      Ilene B. Tannen
       PRIMARY EMAIL FOR CORRESPONDENCE: nytef@jonesday.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): ibtannen@jonesday.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1050 has been submitted with the application, representing payment for 3 class(es).

Declaration

Declaration Signature

Signature: Not Provided    Date: Not Provided
Signatory's Name: Not Provided
Signatory's Position: Not Provided
Signatory's Phone Number: Not Provided
Payment Sale Number: 97124968
Payment Accounting Date: 11/15/2021

Serial Number: 97124968
Internet Transmission Date: Mon Nov 15 12:41:21 ET 2021
TEAS Stamp: USPTO/BAS-XXX.XXX.XX.XX-2021111512412179
5364-97124968-7817481121b9dd7a9bbd994ed1
fb48541b5bb328ed2ffcf4bfaf8845518c4d58fa
-DA-41210097-20211115123209232495

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed